138 related articles for article (PubMed ID: 26700494)
1. Cell signaling in putative leukemic stem cells and blast population in acute myeloid leukemia.
Garg S; Shanmukhaiah C; Ghosh K; Madkaikar M
Leuk Lymphoma; 2016 Sep; 57(9):2195-8. PubMed ID: 26700494
[No Abstract] [Full Text] [Related]
2. CD97 is a critical regulator of acute myeloid leukemia stem cell function.
Martin GH; Roy N; Chakraborty S; Desrichard A; Chung SS; Woolthuis CM; Hu W; Berezniuk I; Garrett-Bakelman FE; Hamann J; Devlin SM; Chan TA; Park CY
J Exp Med; 2019 Oct; 216(10):2362-2377. PubMed ID: 31371381
[TBL] [Abstract][Full Text] [Related]
3. [Heterogeneity of leukemic cell phenotype. II. Variants of hetero- phenotype in relation to myeloid and megakaryocytic markers of leukemia cells in acute leukemia and blast crisis of chronic myeloproliferative disorders].
Kemnitz J; Frend M; Dominis M
Gematol Transfuziol; 1990 Aug; 35(8):15-8. PubMed ID: 2253854
[No Abstract] [Full Text] [Related]
4. [Heterogeneity of leukemia cell phenotype. I. Variants of hetero- phenotype in relation to myeloid and erythrocytic markers of leukemic cells in acute leukemia and blast crisis of chronic myeloproliferative disorders].
Kemnitz J; Helmke M; Frend M; Bür T; Dominis M; Horitz H
Gematol Transfuziol; 1990 Aug; 35(8):9-14. PubMed ID: 2253865
[No Abstract] [Full Text] [Related]
5. Erythrophagocytosis by blasts in acute myeloid leukaemia harbouring the BCR-ABL1 fusion gene.
Murayama H; Matsushita H; Obayashi Y; Ando K
Br J Haematol; 2014 Dec; 167(5):586. PubMed ID: 25256906
[No Abstract] [Full Text] [Related]
6. Nuclear cupping in the blasts-more to the cup than myeloid.
Misra A; Verma D; Chandramohan J; Bakhshi S; Kumar R; Gajendra S; Chopra A
Hematol Oncol; 2016 Sep; 34(3):171-3. PubMed ID: 25370525
[No Abstract] [Full Text] [Related]
7. Recent advances in acute myeloid leukemia stem cell biology.
Horton SJ; Huntly BJ
Haematologica; 2012 Jul; 97(7):966-74. PubMed ID: 22511496
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the proliferative activity and sensitivity to cytosine arabinoside of leukemic blast progenitors in acute myeloblastic leukemia at diagnosis and in relapse.
Nara N; Tohda S; Suzuki T; Nagata K; Tanikawa S; Imai Y; Tomiyama J; Shiina S
Acta Haematol; 1992; 88(1):17-21. PubMed ID: 1414157
[TBL] [Abstract][Full Text] [Related]
9. A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression.
Kikushige Y; Miyamoto T; Yuda J; Jabbarzadeh-Tabrizi S; Shima T; Takayanagi S; Niiro H; Yurino A; Miyawaki K; Takenaka K; Iwasaki H; Akashi K
Cell Stem Cell; 2015 Sep; 17(3):341-52. PubMed ID: 26279267
[TBL] [Abstract][Full Text] [Related]
10. Establishment and Characterization of Long-Term Cultures Derived from Primary Acute Myeloid Leukemia Cells for HDAC Inhibitor Research.
Romanski A; Bug G
Methods Mol Biol; 2017; 1510():127-148. PubMed ID: 27761818
[TBL] [Abstract][Full Text] [Related]
11. A stem cell reporter based platform to identify and target drug resistant stem cells in myeloid leukemia.
Spinler K; Bajaj J; Ito T; Zimdahl B; Hamilton M; Ahmadi A; Koechlein CS; Lytle N; Kwon HY; Anower-E-Khuda F; Sun H; Blevins A; Weeks J; Kritzik M; Karlseder J; Ginsberg MH; Park PW; Esko JD; Reya T
Nat Commun; 2020 Nov; 11(1):5998. PubMed ID: 33243988
[TBL] [Abstract][Full Text] [Related]
12. NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML.
Sasca D; Szybinski J; Schüler A; Shah V; Heidelberger J; Haehnel PS; Dolnik A; Kriege O; Fehr EM; Gebhardt WH; Reid G; Scholl C; Theobald M; Bullinger L; Beli P; Kindler T
Blood; 2019 May; 133(21):2305-2319. PubMed ID: 30814062
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
14. Examination of CD302 as a potential therapeutic target for acute myeloid leukemia.
Lo TH; Abadir E; Gasiorowski RE; Kabani K; Ramesh M; Orellana D; Fromm PD; Kupresanin F; Newman E; Cunningham I; Hart DNJ; Silveira PA; Clark GJ
PLoS One; 2019; 14(5):e0216368. PubMed ID: 31075107
[TBL] [Abstract][Full Text] [Related]
15. Understanding of leukemic stem cells and their clinical implications.
Wang X; Huang S; Chen JL
Mol Cancer; 2017 Jan; 16(1):2. PubMed ID: 28137304
[TBL] [Abstract][Full Text] [Related]
16. Cup-like acute myeloid leukemia: new disease or artificial phenomenon?
Kroschinsky FP; Schäkel U; Fischer R; Mohr B; Oelschlaegel U; Repp R; Schaich M; Soucek S; Baretton G; Ehninger G; Thiede C;
Haematologica; 2008 Feb; 93(2):283-6. PubMed ID: 18223289
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological targeting of β-catenin in normal karyotype acute myeloid leukemia blasts.
Griffiths EA; Golding MC; Srivastava P; Povinelli BJ; James SR; Ford LA; Wetzler M; Wang ES; Nemeth MJ
Haematologica; 2015 Feb; 100(2):e49-52. PubMed ID: 25381132
[No Abstract] [Full Text] [Related]
18. Expression of pSTAT5 predicts FLT3 internal tandem duplications in acute myeloid leukemia.
Obermann EC; Arber C; Jotterand M; Tichelli A; Hirschmann P; Tzankov A
Ann Hematol; 2010 Jul; 89(7):663-9. PubMed ID: 20066533
[TBL] [Abstract][Full Text] [Related]
19. Generation of reactive oxygen intermediates after treatment of blasts of acute myeloblastic leukemia with cytosine arabinoside: role of bcl-2.
Hedley DW; McCulloch EA
Leukemia; 1996 Jul; 10(7):1143-9. PubMed ID: 8683994
[TBL] [Abstract][Full Text] [Related]
20. Hes1 upregulation contributes to the development of FIP1L1-PDGRA-positive leukemia in blast crisis.
Uchida T; Kitaura J; Nakahara F; Togami K; Inoue D; Maehara A; Nishimura K; Kawabata KC; Doki N; Kakihana K; Yoshioka K; Izawa K; Oki T; Sada A; Harada Y; Ohashi K; Katayama Y; Matsui T; Harada H; Kitamura T
Exp Hematol; 2014 May; 42(5):369-379.e3. PubMed ID: 24486648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]